- Company Overview for NATCO PHARMA UK LIMITED (15112743)
- Filing history for NATCO PHARMA UK LIMITED (15112743)
- People for NATCO PHARMA UK LIMITED (15112743)
- More for NATCO PHARMA UK LIMITED (15112743)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
12 Nov 2024 | AA | Accounts for a small company made up to 31 March 2024 | |
08 Apr 2024 | PSC04 | Change of details for Mr Venkaiah Chowdary Nannapaneni as a person with significant control on 1 March 2024 | |
01 Mar 2024 | PSC01 | Notification of Venkaiah Chowdary Nannapaneni as a person with significant control on 1 March 2024 | |
01 Mar 2024 | PSC07 | Cessation of Natco Pharma Limited as a person with significant control on 1 March 2024 | |
05 Feb 2024 | TM01 | Termination of appointment of Brijesh Kumar as a director on 1 November 2023 | |
26 Jan 2024 | AA01 | Current accounting period shortened from 30 September 2024 to 31 March 2024 | |
16 Jan 2024 | RESOLUTIONS |
Resolutions
|
|
05 Jan 2024 | CS01 | Confirmation statement made on 5 January 2024 with updates | |
05 Jan 2024 | SH01 |
Statement of capital following an allotment of shares on 13 October 2023
|
|
05 Oct 2023 | AP01 | Appointment of Mr Brijesh Kumar as a director on 1 October 2023 | |
25 Sep 2023 | PSC05 | Change of details for Natco Pharma Limited as a person with significant control on 25 September 2023 | |
04 Sep 2023 | NEWINC |
Incorporation
Statement of capital on 2023-09-04
|